About Abhishek Bhuyan
Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.
Although Abhishek holds a bachelor's degree in science, his primary goal is to enhance his comprehension of self-learned investment research and provide valuable assistance to retail investors, enabling them to make informed investment decisions.
Recent Articles By Abhishek Bhuyan
3 Bank Stocks Driving Returns Across Industries
The U.S. banking industry is showing signs of recovery due to stabilizing asset quality, potential rate cuts this year, and lower expense growth. Therefore, investors could consider buying fundamentally strong bank stocks Capital Bancorp (CBNK), FS Bancorp (FSBW), and Old Point Financial (OPOF). Read more...
3 Energy Stocks Surging Towards Profitability
The energy industry is poised for robust growth due to increasing global demand for oil amid supply cuts and potential production disruptions. This trend creates opportunities for investment across the sector. Therefore, investors could consider buying fundamentally strong energy stocks such as Phillips 66 (PSX), Cheniere Energy (LNG), and Western Midstream Partners (WES). Keep reading...
3 Tech Stocks Poised for Market Domination
The tech industry looks poised for growth thanks to the growing digitization of business operations and the widespread adoption of cutting-edge technologies across sectors. Against this backdrop, investors could consider buying fundamentally strong tech stocks such as TDK (TTDKY), Seiko Epson (SEKEY), and Gilat Satellite Networks (GILT). Read more...
3 Tobacco Stocks With Promising Future Prospects
Despite various challenges, the tobacco industry is set to grow due to sustained consumption, falling inflation, and the introduction of innovative products. Therefore, investors could consider buying fundamentally strong tobacco stocks such as British American Tobacco (BTI), Vector Group (VGR), and Imperial Brands (IMBBY). Keep reading...
4 Home Improvement Stocks for Sustainable Growth
The home improvement industry promises long-term growth due to rising home starts, growing disposable incomes, falling mortgage rates, and increasing interest in remodeling projects. Given their solid growth prospects, investors could consider buying fundamentally strong home improvement stocks: Mohawk Industries (MHK), Lifetime Brands (LCUT), Alarm.com (ALRM), and Hamilton Beach Brands (HBB). Read more...
3 Tech Stocks Set to Soar Beyond March
The tech industry is benefitting from the growing digitization of business operations and the widespread adoption of cutting-edge technologies. Against this backdrop, investors could consider buying fundamentally strong tech stocks TD SYNNEX (SNX), AvePoint (AVPT), and Proto Labs (PRLB). Read more...
3 Financial Stocks to Enhance Your Investment Portfolio
The financial industry is well-positioned for growth due to the ease of accessibility of digital financial services, evolving consumer lifestyles, and technological advancements. Therefore, investors could consider buying fundamentally strong financial stocks Visa (V), Broadridge Financial Solutions (BR), and FLEETCOR Technologies (FLT). Read more...
3 Auto Stocks With Sky-High Potential for Profits
The auto industry is set for solid growth due to strong consumer demand, robust consumer spending, growth in auto parts sales, the transition to electric vehicles, and growing usage of innovative auto components. Therefore, investors could consider buying fundamentally strong auto stocks: Stellantis (STLA), Mercedes-Benz Group (MBGAF), and Ituran Location and Control (ITRN). Keep reading...
Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?
Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading...